Risks of Taking Weight Loss Supplements

Translate to Spanish or other 102 languages!

 GLP-1 medications are continuing to grow in popularity, but not everyone is eligible for them. As a result, some are opting to take weight-loss supplements instead, which doctors warn can be unsafe. Image for illustration purposes
 GLP-1 medications are continuing to grow in popularity, but not everyone is eligible for them. As a result, some are opting to take weight-loss supplements instead, which doctors warn can be unsafe. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – GLP-1 medications are continuing to grow in popularity, but not everyone is eligible for them. As a result, some are opting to take weight-loss supplements instead, which doctors warn can be unsafe. 

“The problem with supplements is that they are not standardized. GLP-1 medications have been rigorously tested in multiple randomized controlled trials in large cohorts of patients. So, what that means is, they have been tried on multiple patients before they have been deemed safe,” said Peminda Cabandugama, MD, endocrinologist at Cleveland Clinic. 

Dr. Cabandugama said unlike GLP-1 medications, weight-loss supplements do not need to be approved for use by the FDA.

- Advertisement -

That means anything can be added to them, including harmful or illegal ingredients. 

Not to mention, there’s no way to know the potential side effects or long-term risks of taking them. 

Another concern with weight-loss supplements is how they interact with other medications. 

“These supplements could interact with other medications you’re taking, and this can be disastrous if you’re taking any sort of life-saving medication,” Dr. Cabandugama said.

- Advertisement -

If you are currently taking a weight-loss supplement, it’s important to let your physician know because they can offer safer alternatives. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

STHS & Prominence Health Hosting “Senior Living Seminar” on Malnutrition, Sept. 4th

Malnutrition is often an invisible health concern, quietly undermining an older adult's strength, independence and overall quality of life. Yet its warning signs are frequently overlooked or mistaken for a normal part of aging.
- Advertisement -